Welcome to the new version of CaltechAUTHORS. Login is currently restricted to library staff. If you notice any issues, please email coda@library.caltech.edu
Published June 21, 2021 | Submitted
Report Open

Fast and powerful statistical method for context-specific QTL mapping in multi-context genomic studies

Abstract

Recent studies suggest that context-specific eQTLs underlie genetic risk factors for complex diseases. However, methods for identifying them are still nascent, limiting their comprehensive characterization and downstream interpretation of disease-associated variants. Here, we introduce FastGxC, a method to efficiently and powerfully map context-specific eQTLs by leveraging the correlation structure of multi-context studies. We first show via simulations that FastGxC is orders of magnitude more powerful and computationally efficient than previous approaches, making previously year-long computations possible in minutes. We next apply FastGxC to bulk multi-tissue and single-cell RNA-seq data sets to produce the most comprehensive tissue- and cell-type-specific eQTL maps to date. We then validate these maps by establishing that context-specific eQTLs are enriched in corresponding functional genomic annotations. Finally, we examine the relationship between context-specific eQTLs and human disease and show that FastGxC context-specific eQTLs provide a three-fold increase in precision to identify relevant tissues and cell types for GWAS variants than standard eQTLs. In summary, FastGxC enables the construction of context-specific eQTL maps that can be used to understand the context-specific gene regulatory mechanisms underlying complex human diseases.

Additional Information

The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license. This version posted June 18, 2021. N.Z. is supported by NIH grants R01HG006399, R01CA227237, R01CA227466, R01ES029929, R01MH122688, U01HG009080, R01HG011345, R35GM133531, R01HL155024, R01MH125252, DoD grant W81XWH-16-2-0018, and the Chan Zuckerberg Science Initiative. C.J.Y. is supported by the NIH grants R01AR071522, R01AI136972, R01HG011239, and the Chan Zucker berg Science Initiative, and is an investigator at the Chan Zuckerberg Biohub and a member of the Parker Institute for Cancer Immunotherapy (PICI). The GTEx Project was supported by the Common Fund of the Office of the Director of the National Institutes of Health, and by NCI, NHGRI, NHLBI, NIDA, NIMH, and NINDS. Author contributions: B.B. conceived of the project and developed the statistical methods. A.L. and B.B. implemented the comparisons with simulated data. A.L., B.B., M.T., and M.G.G. performed the analyses of the GTEx and CLUES data and additional analyses. B.B. and A.L. implemented the software. A.L. and B.B. wrote the manuscript, with significant input from N.Z., C.J.Y., A.D., M.G.G., and M.T. A.L. and B.B. prepared the online code and data resources. Software Availability: We provide free access to the software at https://github.com/BrunildaBalliu/FastGxC. Due to size limitations, the map of shared and context-specific eQTLs for all GTEx tissues and all CLUES PBMCs is available upon request. Competing interests: C.J.Y. is a Scientific Advisory Board member for and hold equity in Related Sciences and ImmunAI, a consultant for and hold equity in Maze Therapeutics, and a consultant for TReX Bio. C.J.Y. has received research support from Chan Zuckerberg Initiative, Chan Zuckerberg Biohub, and Genentech.

Attached Files

Submitted - 2021.06.17.448889v1.full.pdf

Files

2021.06.17.448889v1.full.pdf
Files (17.1 MB)
Name Size Download all
md5:624d0e824ace7ed3fb40722b354bb3f6
17.1 MB Preview Download

Additional details

Created:
August 20, 2023
Modified:
October 23, 2023